The Patent Finder
US

Hemostasis Device

US 8,523,856 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended Apr 28, 2025 · High confidence

USPTO later recorded it as expired for non-payment on Oct 6, 2025.

Filed Sep 5, 2012 as application 13/604,160 · Granted Sep 3, 2013
Base term, 20 years from filing
Today
20 years from filing
Term ended Apr 28, 2025
2005 2026
Clock starts
Apr 28, 2005
Term ended
Apr 28, 2025
Granted
Sep 3, 2013
base term after the term ends fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,674,260, to Apr 28, 2025. The term already ends on or before that date, so the cap shortened nothing.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Apr 28, 2005, when application 11/118,653, the earliest non-provisional in its chain, was filed (this one was filed Sep 5, 2012)Apr 28, 2025High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 7,674,260)resolves to Apr 28, 2025, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 2 maintenance fees paidterm endedHigh confidence
USPTO status recordRecorded as expired for non-payment on Oct 6, 2025, after the term endedno changeHigh confidence
Computed term endThe steps above, in orderApr 28, 2025High confidence

This family

US 7,674,260In force
Nov 2026
Nov 2026
Application PCT/US2006/014898PCT application
no patent term
no patent term
US 8,277,445Lapsed on the fee record
Oct 2024
Oct 2024
US 8,523,856this patent
Apr 2025
Apr 2025
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Sep 10, 2012
Reel 28927, frame 105
Sampson, Russel M.; Skalnyi, Eugene V.Cytyc CorporationAssignment of Assignor's Interest
Nov 20, 2012
Reel 29340, frame 249
Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe IncorporatedGoldman Sachs Bank USAFirst Supplement to Patent Security Agreement
Jul 17, 2015
Reel 36128, frame 1
Goldman Sachs Bank USA, as Collateral AgentHologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe IncorporatedSecurity Interest Release Reel/Frame 029340/0249
Jul 17, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentHologic, Inc.Security Interest Release Reel/Frame 029340/0249
Jul 17, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentBiolucent, LLCSecurity Interest Release Reel/Frame 029340/0249
Jul 17, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentCytyc CorporationSecurity Interest Release Reel/Frame 029340/0249
Jul 17, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentCytyc Surgical Products, Limited PartnershipSecurity Interest Release Reel/Frame 029340/0249
Jul 17, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentDirect Radiography Corp.Security Interest Release Reel/Frame 029340/0249
Jul 17, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentSuros Surgical Systems, Inc.Security Interest Release Reel/Frame 029340/0249
Jul 17, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentThird Wave Technologies, Inc.Security Interest Release Reel/Frame 029340/0249
Jul 17, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentGen-Probe IncorporatedSecurity Interest Release Reel/Frame 029340/0249
Aug 7, 2015
Reel 36307, frame 199
Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.Bank of America, N.A., as Collateral AgentSecurity Agreement
Apr 28, 2026
Reel 75566, frame 39
Bank of America, N.A., as Collateral AgentHologic, Inc., on Its Own Behalf and as Successor-by-Merger to Direct Radiography Corp.; Cytyc Corporation, on Its Own Behalf and as Successor-by-Merger to Biolucent, LLC; Cytyc Surgical Products, LLC, as Successor-by-Conversion to Cytyc Surgical Products, Limited Partnership; Gen-Probe Incorporated, on Its Own Behalf and as Successor-by-Merger to Third Wave Technologies, Inc.; Gen-Probe Prodesse, Inc.; Suros Surgical Systems, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited